Aspect Biosystems
Aspect Biosystems is a Canadian biotechnology company focused on creating bioprinted tissue therapeutics to transform disease treatment. Their innovative platform integrates AI-powered bioprinting, computational design, therapeutic cells, and biomaterials to develop allogeneic tissue therapeutics for regenerative medicine, metabolic, and endocrine diseases. They collaborate globally with industry and academic partners to advance research and develop impactful therapies.
Industries
Nr. of Employees
medium (51-250)
Aspect Biosystems
Vancouver, British Columbia, Canada, North America
Products
Full‑stack tissue therapeutic platform
Integrated platform combining microfluidic 3D bioprinting, computational design, therapeutic cells, and biomaterials to develop implantable allogeneic tissue therapeutics.
Microfluidic bioprinter instrument
Laboratory-scale microfluidic bioprinting instrument designed to fabricate 3D tissue constructs for research and translational applications.
Pipeline of implantable bioprinted tissue therapeutics
In-house therapeutic programs focused on implantable bioprinted tissues targeting metabolic and endocrine diseases (including pancreatic, liver, and related indications).
Full‑stack tissue therapeutic platform
Integrated platform combining microfluidic 3D bioprinting, computational design, therapeutic cells, and biomaterials to develop implantable allogeneic tissue therapeutics.
Microfluidic bioprinter instrument
Laboratory-scale microfluidic bioprinting instrument designed to fabricate 3D tissue constructs for research and translational applications.
Pipeline of implantable bioprinted tissue therapeutics
In-house therapeutic programs focused on implantable bioprinted tissues targeting metabolic and endocrine diseases (including pancreatic, liver, and related indications).
Services
Collaborative R&D partnerships
Co-development arrangements with academic and industry partners to develop tissue models and implantable tissue therapeutics; includes technology transfer and joint development.
Platform access and technology deployment
Provision of access to the company's tissue fabrication platform and associated protocols to enable external research and development projects.
Collaborative R&D partnerships
Co-development arrangements with academic and industry partners to develop tissue models and implantable tissue therapeutics; includes technology transfer and joint development.
Platform access and technology deployment
Provision of access to the company's tissue fabrication platform and associated protocols to enable external research and development projects.
Expertise Areas
- 3D bioprinting and biofabrication
- Microfluidics
- Biomaterials and hydrogel engineering
- Tissue engineering and regenerative medicine
Key Technologies
- Microfluidic 3D bioprinting
- Computational tissue design
- AI-driven design workflows
- Bio-ink and hydrogel formulation